Skip to Content

93 T13 (Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release 60 mg / 120 mg)

Pill with imprint 93 T13 is Tan & White, Capsule-shape and has been identified as Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release 60 mg / 120 mg. It is supplied by Teva Pharmaceuticals USA.

Fexofenadine/pseudoephedrine is used in the treatment of allergic rhinitis and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Fexofenadine/pseudoephedrine 60 mg / 120 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 T13

Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release

Imprint
93 T13
Strength
60 mg / 120 mg
Color
Tan & White
Size
19.00 mm
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
Upper respiratory combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00093-1130

Get help with Imprint Code FAQs.

Related Images for "93 T13"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.